Results 61 to 70 of about 1,145 (113)

Advancements in development of novel class of HIV protease inhibitors. [PDF]

Ann Med
Gu WG, Yin GZ, Zhang YP.
europepmc   +1 more source

Physiologically based pharmacokinetic modeling of drug-drug interactions between ritonavir-boosted atazanavir and rifampicin in pregnancy. [PDF]

CPT Pharmacometrics Syst Pharmacol
Atoyebi S, Montanha MC, Nakijoba R, Orrell C, Mugerwa H, Siccardi M, Denti P, Waitt C.   +7 more
europepmc   +1 more source

Antiretroviral medications for pediatric use in the context of the Unified Health System: are there therapeutic gaps in Brazil? [PDF]

Rev Paul Pediatr
Costa SMD, Aguiar PM.
europepmc   +1 more source

Interactions between long-acting antiretrovirals and opioids: a call for clinical awareness. [PDF]

Clin Microbiol Rev
Carbajal C, Owens F, Veeragoni D, Rodriguez M, Fernandez-Lima F, Nefzi A, Buch S, El-Hage N.   +7 more
europepmc   +1 more source

Second-Line Antiretroviral Therapy for Children Living with HIV in Africa. [PDF]

N Engl J Med
Musiime V, Bwakura-Dangarembizi M, Szubert AJ, Mumbiro V, Mujuru HA, Kityo CM, Lugemwa A, Doerholt K, Chabala C, Makumbi S, Mulenga V, McIlleron H, Burger D, Natukunda E, Shakeshaft C, Linda KJ, Nathoo K, Monkiewicz L, Yawe I, Kapasa M, Nyathi M, Lungu J, Nduna B, Ndebele W, South A, Mwamabazi M, Musoro G, Griffiths A, Zyambo K, Nazzinda R, Zimba K, Zhang Y, Walker S, Turkova A, Walker AS, Bamford A, Gibb DM, CHAPAS-4 Trial Team.   +37 more
europepmc   +1 more source

Evaluation of the Role of Tanshinone I in an In Vitro System of Charcot-Marie-Tooth Disease Type 2N. [PDF]

Int J Mol Sci
Zhang J, Meng X, Qin Q, Liang Y, Yang G, Li S, Li X, Zhou JC, Sun L.   +8 more
europepmc   +1 more source

Bariatric surgery and HIV: Joint venture between family, primary care, and HIV physicians. [PDF]

J Family Med Prim Care
Aydemir C, Al Saidi R, Choi JS, Ahmed MH, Mital D.   +4 more
europepmc   +1 more source

Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin. [PDF]

Clin Infect Dis
Gausi K, Mugerwa H, Siccardi M, Montanha MC, Lamorde M, Wiesner L, D'Avolio A, McIlleron H, Wilkins E, De Nicolò A, Maartens G, Khoo S, Kityo C, Denti P, Waitt C.   +14 more
europepmc   +1 more source

The emerging pathogen Candida auris: host interactions and disease drivers. [PDF]

J Biomed Sci
Sanya DRA, Arevalo AV, Onésime D, Nobile CJ.   +3 more
europepmc   +1 more source

Enhanced antifungal activity of posaconazole against Candida auris by HIV protease inhibitors, atazanavir and saquinavir. [PDF]

Sci Rep
Elgammal Y, Salama EA, Seleem MN.
europepmc   +1 more source